Sign In

Julian Berger

Scientist at Columbia University; Druckenmiller Fellow at The New York Stem Cell Foundation Research Institute

Julian Meyer Berger, PhD, is a scientist and entrepreneur in the field of bone biology and endocrinology. He is the Founder and CEO of Osteologic Therapeutics, a company focused on harnessing the skeleton to create transformative medicines.2 Dr. Berger was a 2021 NYSCF – Druckenmiller Fellow at The New York Stem Cell Foundation Research Institute.2

Dr. Berger's research focuses on identifying new hormones derived from bone, finding the cells that generate these hormones within bone, and designing novel therapeutics to enhance the bone endocrine system.2 His work has potential implications for various diseases affected by the bone endocrine system, including psychiatric diseases, neuromuscular junction disorders, and metabolic syndromes.2

Dr. Berger received his PhD in Immunology from Columbia University.12 His academic background and research interests have positioned him at the forefront of bone-related medical research and drug development.

Highlights

Oct 8 · nyscf.org
Julian Meyer Berger, PhD
Mar 6 · scienceopen.com
An analysis of the UK's commercial stem cell clinics
Michael Berger
Machine Learning Identifies Stemness Features ...

Related Questions

What are Julian Meyer Berger's main research interests?
How does Julian Meyer Berger's work at Osteologic Therapeutics impact the field of immunology?
What are the key findings from Julian Meyer Berger's PhD thesis at Columbia University?
How does Julian Meyer Berger's role as a Druckenmiller Fellow at the New York Stem Cell Foundation contribute to his research?
What are the potential applications of the new hormones derived from bone identified by Julian Meyer Berger?
Julian Berger
Add to my network

Location

New York, New York, United States